Monitored anesthesia care for the acute ischemic stroke patient with end-stage pulmonary disease
Author(s) -
Kevin C. Lee,
BrianC Lee,
StevenE Miller
Publication year - 2017
Publication title -
anesthesia essays and researches
Language(s) - English
Resource type - Journals
ISSN - 0259-1162
DOI - 10.4103/aer.aer_95_17
Subject(s) - medicine , extracorporeal membrane oxygenation , anesthesia , recombinant tissue plasminogen activator , stroke (engine) , tissue plasminogen activator , anesthetic , thrombolysis , ischemic stroke , ischemia , cardiology , myocardial infarction , mechanical engineering , modified rankin scale , engineering
The majority of patients who suffer acute ischemic stroke (AIS) from large vessel occlusion are at a significant risk for disability or death. Because patients on veno-arterial extracorporeal membrane oxygenation (VA ECMO) are therapeutically anticoagulated, intravenous recombinant tissue plasminogen activator is contraindicated. For AIS management, these patients must undergo emergent intra-arterial therapy. Presented is a patient on VA ECMO who subsequently suffered a large vessel embolic stroke requiring emergent surgical intervention. The decision by our anesthetic team to perform the procedure under monitored anesthesia care is discussed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom